A detailed history of Hantz Financial Services, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 200 shares of MNKD stock, worth $1,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 940 78.72%
Holding current value
$1,360
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.01 - $6.7 $3,707 - $4,958
-740 Reduced 78.72%
200 $1,000
Q2 2024

Jul 30, 2024

BUY
$4.05 - $5.43 $3,807 - $5,104
940 New
940 $5,000
Q4 2022

Aug 06, 2024

SELL
$3.02 - $5.37 $604 - $1,074
-200 Reduced 17.09%
970 $5,000
Q1 2022

Aug 06, 2024

BUY
$2.62 - $4.45 $602 - $1,023
230 Added 24.47%
1,170 $4,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.75B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.